CyberKnife treatment for multiple brain metastases
Part of Brain & nervous system, Cancer, Lungs & breathing clinical trials.
This trial looks at how well (and how much) CyberKnife radiation works for people with multiple brain metastases. It may help your care team understand the best way to treat several brain spots safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (age 18 or older).
- You have a confirmed cancer diagnosis from tissue testing, and it has spread to the brain in multiple spots.
- Your brain MRI shows about 4 to 15 suspicious lesions (spots), not more than 15.
- You can have the planned radiation safely, and you can tolerate the treatment plan.
- You can do MRI scans (no certain metal/implant issues like some pacemakers/defibrillators).
- If you could become pregnant, you can use reliable birth control; you are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new radiation approach for people with small cell lung cancer that has spread to the brain. It combines whole-brain radiation that avoids the memory centers, followed by focused radiation to the tumors, while you also receive standard chemotherapy and immunotherapy.
This trial tests whether combining brain radiation with chemotherapy and immunotherapy can help people with advanced lung cancer that has spread to the brain but has not yet been treated. It is for those whose tumors do not have certain gene mutations (EGFR, ALK, ROS1).
This trial tests a new approach for people with a single large brain tumor that has spread from another cancer. You would receive a short, focused dose of radiation (stereotactic radiosurgery) in small, separate treatments, followed by surgery to remove the tumor. The goal is to see if this combination works better than the usual treatment.
This trial is for people with cancer that has spread to the brain (brain metastases). It tests a new approach where you start a systemic therapy (drugs that travel through your body) and later add focused radiation to the brain tumors, instead of treating them right away. The goal is to see if this sequence works well and avoids unnecessary side effects.
This Phase 2 study tests a precise, no-head-frame radiation technique to treat brain metastases. It may help by aiming radiation tightly at the tumors while limiting exposure to nearby healthy brain.
This trial tests CyberKnife, a precise radiation treatment, for melanoma that has spread to the brain. It may help you if you haven't had whole-brain radiation or brain surgery before.
Hear when a new Brain Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.